This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AJG Stock Trades at a Discount: Time to Invest or Hold Off?
by Zacks Equity Research
Arthur J. Gallagher drives steady growth with strong operations and acquisitions, though rising costs and debt weigh on profitability.
Zacks Industry Outlook Highlights Brown and Brown, Marsh & McLennan, Arthur J. Gallagher and Willis Towers Watson Public
by Zacks Equity Research
Despite near-term headwinds, Brown and Brown, Marsh & McLennan, Arthur J. Gallagher and Willis Towers Watson are leveraging growth drivers in insurance brokerage.
4 Insurance Brokerage Stocks to Watch Amid Increased Digitalization
by Sushmita Sarker
Zacks Insurance Brokerage players like BRO, MMC, AJG and WTW are likely to benefit from increased demand for insurance products, strategic acquisitions and the adoption of technology.
Is the Options Market Predicting a Spike in Arthur J. Gallagher Stock?
by Zacks Equity Research
Investors need to pay close attention to AJG stock based on the movements in the options market lately.
How Brown & Brown's Wholesale Brokerage Fuels Growth Momentum?
by Zacks Equity Research
BRO's Wholesale Brokerage fuels steady growth and resilience, reinforcing its role as a cornerstone of the business.
How Is Willis Towers' Risk & Broking Division Powering Growth Momentum?
by Zacks Equity Research
WTW's Risk & Broking unit drives momentum with rising revenue, stronger margins, and solid client retention, fueling sustainable growth.
How Does the Brokerage Segment Shape Arthur J. Gallagher's Success?
by Zacks Equity Research
AJG's Brokerage segment fuels growth with acquisitions, tech upgrades, and stronger client trust.
Willis Towers Trades Above 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
WTW drives growth with efficiency and a client-focused approach but rising costs and foreign exchange risks pressure margins.
Arthur J. Gallagher Trades Below 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
AJG benefits from acquisitions and strong brokerage demand, but rising costs and debt weigh on margins and returns.
Brown & Brown Trades Below 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
BRO benefits from acquisitions and strong liquidity amid premium valuation and weaker profitability.
Top Stock Reports for JPMorgan Chase, Chevron & Shopify
by Mark Vickery
JPMorgan Chase posts 43.9% annual gain, fueled by loan demand and high rates, but faces expense growth and asset quality concerns.
Arthur J. Gallagher Q2 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
AJG's Q2 revenue climbs 16% on strong fee and finance income, but EPS slips short of expectations.
Arthur J. Gallagher (AJG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Arthur J. Gallagher (AJG) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Arthur J. Gallagher (AJG) Q2 Earnings Miss Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of -1.27% and +0.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
First Interstate BancSystem (FIBK) Q2 Earnings Top Estimates
by Zacks Equity Research
First Interstate BancSystem (FIBK) delivered earnings and revenue surprises of +21.05% and -1.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
What's in the Cards for Arthur J. Gallagher This Earnings Season?
by Zacks Equity Research
AJG's Q2 results are likely to reflect solid retention, strategic acquisitions, improved investment income, as well as higher renewal premiums.
Arthur J. Gallagher (AJG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AJG Picks Equinox to Expand Health Benefit Services in Pennsylvania
by Zacks Equity Research
Arthur J. Gallagher strengthens its presence in Pennsylvania through the Equinox acquisition, enhancing its reach in health benefits consulting.
BRO Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Brown & Brown stock remains poised to gain from new business, solid retention, higher core commissions and fees, strategic buyouts and prudent capital deployment.
WTW Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Willis Towers stock rallies on the back of a strong new business, strategic acquisitions, solid customer retention levels and financial flexibility.
Implied Volatility Surging for Arthur J. Gallagher Stock Options
by Zacks Equity Research
Investors need to pay close attention to AJG stock based on the movements in the options market lately.
Zacks Industry Outlook Highlights Brown and Brown, Marsh & McLennan, Arthur J. Gallagher and Willis Towers Watson Public
by Zacks Equity Research
Despite near-term headwinds, BRO, MMC, AJG, and WTW show resilience through M&A and tech-led growth.
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Sushmita Sarker
The increased demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like ERIE, BRO, MMC, AJG and WTW.
Should iShares Russell Mid-Cap ETF (IWR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWR